z-logo
open-access-imgOpen Access
Direct Observation of Methylmercury and Auranofin Binding to Selenocysteine in Thioredoxin Reductase
Author(s) -
Ingrid J. Pickering,
Qing Cheng,
Emérita Mendoza Rengifo,
Susan Nehzati,
Natalia V. Dolgova,
Thomas Kröll,
Dimosthenis Sokaras,
Graham N. George,
Elias S.J. Arnér
Publication year - 2020
Publication title -
inorganic chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.348
H-Index - 233
eISSN - 1520-510X
pISSN - 0020-1669
DOI - 10.1021/acs.inorgchem.9b03072
Subject(s) - chemistry , auranofin , thioredoxin reductase , selenocysteine , methylmercury , thioredoxin , biochemistry , stereochemistry , cysteine , enzyme , selenium , organic chemistry , medicine , rheumatoid arthritis
Selenoenzymes, containing a selenocysteine (Sec) residue, fulfill important roles in biology. The mammalian thioredoxin reductase selenoenzymes are key regulators of antioxidant defense and redox signaling and are inhibited by methylmercury species and by the gold-containing drug auranofin. It has been proposed that such inhibition is mediated by metal binding to Sec in the enzyme. However, direct structural observations of these classes of inhibitors binding to selenoenzymes have been few to date. Here we therefore have used extended X-ray absorption fine structure as a direct structural probe to investigate binding to the selenium site in recombinant rat thioredoxin reductase 1 (TrxR1). The results demonstrate for the first time the direct and complete binding of the metal atom of the inhibitors to the selenium atom in TrxR1 for both methylmercury and auranofin, indicating that TrxR1 inhibition indeed can be attributed to such direct metal-selenium binding.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom